Detalhe da pesquisa
1.
Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China.
Qual Life Res
; 32(3): 915-922, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692593
2.
Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey.
Health Qual Life Outcomes
; 19(1): 140, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962617
3.
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension.
Eur Respir J
; 56(5)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513782
4.
Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension.
Eur Respir J
; 53(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578397
5.
Liquid chromatography mass spectrometry-based profiling of phosphatidylcholine and phosphatidylethanolamine in the plasma and liver of acetaminophen-induced liver injured mice.
Lipids Health Dis
; 16(1): 153, 2017 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807032
6.
Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.
Gut
; 65(10): 1611-8, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26129866
7.
BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension.
Lung
; 192(4): 625-7, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24728306
8.
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Hepatol Int
; 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878111
9.
Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study.
BMJ Open
; 13(6): e062131, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339833
10.
[Pulmonary embolism in patients with chronic obstructive pulmonary disease exacerbations of unknown origin: clinical characteristics and risk factors].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(4): 259-63, 2012 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-22781197
11.
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease.
Front Med (Lausanne)
; 9: 979959, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405582
12.
Case Report: Clinical characteristics and genetic analysis of two patients with hereditary hemorrhagic telangiectasia.
Front Genet
; 13: 954796, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092899
13.
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
Aliment Pharmacol Ther
; 55(10): 1297-1310, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362188
14.
[Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis].
Zhonghua Gan Zang Bing Za Zhi
; 19(10): 782-4, 2011 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-22409854
15.
[General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi
; 19(5): 362-6, 2011 May.
Artigo
em Zh
| MEDLINE | ID: mdl-21645445
16.
Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B.
J Gastroenterol Hepatol
; 25(9): 1569-77, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20796157
17.
Beta-blockers in COPD: A systematic review based on recent research.
Life Sci
; 252: 117649, 2020 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275936
18.
Development of new drugs for the treatment of nonalcoholic steatohepatitis.
J Dig Dis
; 21(1): 3-11, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682309
19.
[Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study].
Zhonghua Gan Zang Bing Za Zhi
; 17(3): 213-6, 2009 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-19335986
20.
[Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
Zhonghua Gan Zang Bing Za Zhi
; 17(11): 847-51, 2009 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-19958646